Swedish Orphan Biovitrum AB
Overview
Swedish Orphan Biovitrum AB, commonly known as Sobi, is a biopharmaceutical company headquartered in Sweden. The company specializes in rare diseases and is dedicated to developing and delivering innovative therapies for patients with high unmet medical needs around the globe.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Swedish Orphan Biovitrum AB in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Swedish Orphan Biovitrum AB? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.